Mark Wathen is a Cardiology physician affiliated with Vanderbilt University. OpenAlex indexes 36 publications with 4,428 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
228 W 4th St
Suite 200
Cookeville, TN 385012488
Telephone
931-372-0405Provider last certified this registry record 17 Jun 2022.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biosense Webster, Inc.Program year20254 payments
- Boston Scientific CorporationProgram year20253 payments
- Medtronic, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
63.5%Antiarrhythmic31.1%Amiodarone Hcl47%Flecainide Acetate35%Dofetilide15%Propafenone Hcl3%Part D<11 patientsBeta blocker25.1%Sotalol38%Metoprolol Tartrate27%Metoprolol Succinate20%Carvedilol8%Propranolol Hcl5%Sotalol Af2%Part D<11 patients+ 5 more classes in this area
Blood & clotting
36%Factor Xa inhibitor26.5%Eliquis80%Xarelto20%Part D≥156 patientsVitamin K antagonist6%Warfarin Sodium100%Part D≥45 patients+ 2 more classes in this area
Metabolism & gastrointestinal
0.5%Potassium supplement0.5%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1994–1995 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Regional Research Intensive Clusters and Science Parks
Fraunhofer-Publica (Fraunhofer-Gesellschaft)
2016 - Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT)
The American Journal of Cardiology
2016 - Combining Shock Reduction Strategies to Enhance ICD Therapy: A Role for Computer Modeling
Journal of Cardiovascular Electrophysiology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
James Crowe, MD
Vanderbilt University
Ingrid Mayer, MD
Vanderbilt University
Michael Debaun, MD
Vanderbilt University
Sam Chang, MD
Vanderbilt University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”